Wedbush Securities Inc Galectin Therapeutics Inc Transaction History

Wedbush Securities Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$1.1 - $2.4 $9,900 - $21,600	-9,000 Reduced 36.74%	15,498 $33,000
Q4 2022 Jan 31, 2023	SELL	$1.03 - $1.66 $515 - $830	-500 Reduced 2.0%	24,498 $28,000
Q3 2022 Oct 18, 2022	SELL	$1.31 - $2.48 $3,930 - $7,440	-3,000 Reduced 10.72%	24,998 $0
Q1 2022 Apr 19, 2022	SELL	$1.61 - $2.31 $3,220 - $4,620	-2,000 Reduced 6.67%	27,998 $45,000
Q4 2021 Jan 13, 2022	SELL	$2.07 - $3.8 $2,070 - $3,800	-1,000 Reduced 3.23%	29,998 $62,000
Q3 2021 Oct 08, 2021	BUY	$2.59 - $4.15 $33,670 - $53,950	13,000 Added 72.23%	30,998 $120,000
Q1 2021 Apr 26, 2021	SELL	$1.96 - $2.57 $4,900 - $6,425	-2,500 Reduced 12.2%	17,998 $39,000
Q4 2020 Feb 16, 2021	BUY	$2.24 - $2.87 $6,720 - $8,610	3,000 Added 17.14%	20,498 $46,000
Q3 2020 Oct 20, 2020	SELL	$2.53 - $3.64 $7,589 - $10,920	-3,000 Reduced 14.64%	17,498 $47,000
Q1 2020 Apr 17, 2020	SELL	$1.51 - $3.0 $1,510 - $3,000	-1,000 Reduced 4.65%	20,498 $40,000
Q3 2019 Oct 17, 2019	SELL	$3.0 - $4.05 $9,000 - $12,150	-3,000 Reduced 12.25%	21,498 $79,000
Q2 2019 Aug 01, 2019	BUY	$3.61 - $5.0 $23,465 - $32,500	6,500 Added 36.12%	24,498 $102,000
Q2 2018 Aug 03, 2018	SELL	$3.16 - $9.16 $56,880 - $164,880	-18,000 Reduced 50.0%	17,998 $114,000
Q1 2018 May 01, 2018	BUY	$3.78 - $5.97 $20,786 - $32,829	5,499 Added 18.03%	35,998 $171,000
Q4 2017 Feb 09, 2018	BUY	$1.54 - $3.34 $46,968 - $101,866	30,499	30,499 $102,000

10M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $73.1M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.